[-] Show simple item record

dc.contributor.authorRicco, Jasoneng
dc.contributor.authorBenson, Janiceeng
dc.contributor.authorPrasad, Shailendraeng
dc.contributor.otherFamily Physicians Inquiries Networkeng
dc.date.issued2017eng
dc.description.abstractThis study should put to rest the practice of starting SSRIs in depressed patients with heart failure in an attempt to affect CVD outcomes. PRACTICE CHANGER: Do not prescribe selective serotonin reuptake inhibitors to improve depression and reduce cardiovascular risk in patients with congestive heart failure. Stength of recommendation: B: Based on one large randomized controlled trial.eng
dc.identifier.urihttps://hdl.handle.net/10355/61540
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofcollectionPriority Updates to Research Literature (PURLs) (2017)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.relation.ispartofseriesJournal of family practice, 66, no. 09 (September 2017): 564-567.eng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subject.otherSerotonin reuptake inhibitorseng
dc.subject.otherDepressioneng
dc.subject.otherCardiovascular riskeng
dc.subject.otherCongestive heart failureeng
dc.subject.otherEscitaloprameng
dc.subject.otherSertralineeng
dc.titleSSRIs for depression/heart failure patients? Not so fasteng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record